EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

The European stock markets closed higher in Tuesday trading as the Stoxx Europe 600 rose 0.58%, the Swiss Market Index climbed 0.70%, France's CAC increased 1.28%, the FTSE in London gained 0.28%, and ...

Pharmaceutical and biotechnology company GSK said on Tuesday that the European Medicine Agency has recommended meningococcal ...

(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Human Use. The London-based pharmaceutical company ...

GSK plc (GSK, GSK.L) announced the European Medicine Agency's Committee for Medicinal Products for Human Use or CHMP has recommended ...

Building materials supplier CRH has appointed Chief Financial Officer Jim Mintern, a board director since June 2021, as its new chief executive officer. He succeeds Albert Manifold, who plans to ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK – Research Report), Sonova Holding AG (CH:SOON – Research Report) and Corbus Pharmaceuticals ...

GSK plc (LSE/NYSE: GSK), a leading pharmaceutical company, has announced the discontinuation of its phase III development plans for the herpes simplex virus (HSV) vaccine candidate, GSK3943104 ...

(Reuters) – British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward ...

Previously head of GSK’s consumer health division, Walmsley joined the company in 2010 after spending 17 years at L’Oreal. Witty has been in charge of GSK since 2008 and is paid nearly £1.1 ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

GSK Plc ’s experimental drug helped prevent serious asthma attacks in two late-stage studies, easing the path forward for a medicine that the British company says could reach £3 billion ($3.9 billion) ...